«BioEq» recruits for healthy females to participate in a phase III clinical study with a contraceptive.
The drug consist of ethinyl estradiol and etonogestrel as compared with NovaRing
We invite healthy females –from 18 to 40 years without excess weight. Women with regular menstrual cycle of 21-35 days who are ready to use the intravaginal ring as the main method of contraception while participating in the study
Please contact us at 8-812-945-22-32 to learn more.